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ABSTRACT 
 
In 2004 Emanuel and colleagues analysed most major existing ethics codes and produced a framework 
of eight principles and benchmarks to guide Research Ethics Committees (RECs) during review of 
research proposals. Although the framework was intended for use in all settings, it is not known 
whether the ethical issues raised by a Malawian REC are compatible with the framework. This study 
sought to identify the main ethical issues raised during review of research proposals submitted to a 
Malawian REC and assess their comparability with the Emanuel et al. (2004) principles and 
benchmarks. 
 
Protocol review minutes of 2013 and 2014 meetings were analysed. The minutes contained the 
concerns that applicants received. Only minutes of newly submitted applications were included in the 
study. We excluded expedited and continuing reviews, annual reports, protocol resubmissions and 
reports. 
During the study period there were 139 protocols for initial submission. In total, the REC raised 1274 
concerns.  Of these, 88.8% were accommodated or coded using the eight principles of the Emanuel et 
al. Framework (2004) as follows; scientific validity (38.3%), informed consent (22.1%), independent 
review (9.3%), collaborative partnership (4.7%), respect for recruited participants (3.8%), social value 
(3.7%), favourable risk benefit ratio (3.5%) and fair selection of study population (2.9%). Other non-
ethical or administrative concerns frequently raised were language errors (9.7%) and inappropriate 
referencing and plagiarism (2%). 
Most ethical concerns raised by the Malawian REC were compatible with the Emanuel et al. framework 
(2004). Scientific design and inappropriate research methods are major concerns raised during 
protocol review implying that the REC is protecting human subjects from participating in studies that 
require strengthening of their scientific merit.  
Keywords: Malawi, research ethics committee, REC, Emanuel et al. framework, queries, 
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CHAPTER 1: INTRODUCTION 
 
1.1  Introduction and background 
This chapter will briefly introduce the research and its background. Research that involves human participants 
is crucial in order to generate knowledge that is beneficial to individuals and society as a whole. The 
overarching question is: How can we uphold the rights and dignity of human subjects within the demands of 
scientific enterprise (Emanuel, Crouch, Arras, Moreno, & Grady, 2008).  
 
Numerous international guidelines for ethical conduct of research emerged after the revelations of brutal 
medical experiments in the past, and became a blueprint for research guidelines in various jurisdictions. 
Among these international guidelines, one of the fundamental recommendations is to conduct independent 
review of research protocols (CIOMs, 2016; OHRP, 2009; World Medical Association (WMA), 2000). 
Independent committees in the United States are known as institutional review boards (IRBs), elsewhere they 
are called research ethics committees (RECs) (Kass, Hyder, Ajuwon, … & Tindana, 2007). They have a duty to 
provide oversight of health research as well as provide a public forum for the accountability of researchers 
(Ashcroft & Pfeffer, 2001).  When the REC is reviewing a research protocol, it can typically come to the 
decision that a given project: (1) is acceptable as presented, (2) needs to be modified before it can be 
accepted, (3) requires more information to make a decision, or (4) is unacceptable in its current form.  
 
Typically, RECs rely on international and national guidelines to review research protocols. However, several 
sets of international guidelines exist and there are concerns about how to interpret and harmonise some 
clauses within these guidelines. In an effort to help RECs in their work, Emanuel and colleagues (2004, 2008) 
analysed existing ethical codes and produced a framework of eight principles as benchmarks to guide the 
review of research proposals in developing countries. Although the Emanuel, Wendler and Grady (2008) 
framework was intended for use in low and middle-income countries, it is unknown whether the ethical 
issues arising from REC review in these settings are compatible with the framework (Tsoka-Gwegweni & 
Wassenaar, 2014). 
  
Given the cultural, political, and educational background, as well as disease burden and socio-economic 
situations that usually influence health research in Africa, there is a need to assess the applicability of this 
framework to different settings. For instance, Malawi is a low-income sub-Saharan Africa country with a gross 
national product (GDP) of US$ 360 billion. It is 118,480 km² in size with a population of 16.36 million (IMF, 
2014). The country has a very high disease burden that has put pressure on health care management. Almost 
10.6% of the population in Malawi is HIV infected (Malawi Demographic and Health Survey, 2012). Due to 
the high disease burden, the country has become a popular destination for international collaborative 
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research. Understanding the compatibility of the Emanuel et al. framework (2004, 2008) to the Malawian 
setting is necessary. 
 
Ethics review of protocols started in 1988 in Malawi. Currently, the RECs mandated to review research 
proposals are the National Health Science Research Committee (NHSRC), the College of Medicine Research 
Ethics Committee (COMREC) (Mfutso-Bengo, Manda-Taylor, Jumbe, Kazanga & Masiye, 2014) and the 
National Committee on Research in the Social Sciences and Humanities (NCRSH) (M. Kachedwa, personal 
communication, April 7, 2017). Since the establishment of these RECs there has been no study to evaluate 
their operations.   The report by the office of the Inspector General of the United States Government 
cautioned that REC processes must be monitored and evaluated because they play a vital role in research 
enterprise. The report stated that evaluations can allow easy identification of areas that require improvement 
to ensure that the REC is protecting human subjects effectively, is operating efficiently, and that it has 
adequate authority (Protecting Human Research Subjects Status Recommendation, 2000). In this case, the 
Emanuel et al. (2008) framework was used to evaluate the concerns of one Malawian REC. This is the first 
empirical study reporting on the ethical concerns raised by a Malawian REC.  The study used a qualitative 
approach to analyse minutes of protocol review meetings. The main study aims were to identify ethical issues 
frequently raised during review of research proposals and then assess their relative weight using Emanuel et 
al.’s (2008) framework. This is a replication of a South African study done by Tsoka-Gwegweni and Wassenaar 
(2014). 
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CHAPTER 2: LITERATURE REVIEW 
 
2.1  Towards regulatory practices for research involving human participants 
Several scandals and tragedies in past medical experiments stimulated the need to regulate research 
activities. This has also led to research ethics as a discipline which aims at protecting the rights and welfare 
of those volunteering to participate in research. Of course, presently research ethics is extending into areas 
such as scientific misconduct and plagiarism (Wassenaar, 2006). When revelations of brutal medical 
experiments were made, numerous guidelines for ethical conduct of research were developed. For instance 
the Nazi war crime ruling lead to the Nuremberg code and the Tuskegee syphilis study facilitated the creation 
of the US Common Rule and the Belmont Report. Most of these guidelines have recommended the 
independent review of research protocols (WMA, 2000; CIOMS, 2016). Additionally, many individual 
countries have also developed legislation that regulates research involving humans (Mokgatla, IJsselmuiden, 
Wassenaar et al., 2017).  
 
In Malawi (Mfutso-Bengo, 2015) ethics review of research started in 1988 but the strengthening of the 
Malawian ethics review system came after there were changes in United States (US) research policy on 
research funding for overseas studies in 2001. There was a requirement that any US government-funded 
research involving human research volunteers had to follow the prescribed US regulations (Mfutso-Bengo, 
2015). This US research ethics requirement was a blessing in disguise to improve the operations of Malawian 
RECs. Later, in 2005, a document was developed known as the National Policy Measures and Requirements 
for the Improvement of Health Research Co-ordination in Malawi (National Commission for Science and 
Technology, 2012). The policy document was revised in 2012 and it provides guidance to research institutions, 
researchers and RECs on how they ought to operate in the country.     
 
Below, selected scandals and guidelines are reviewed, especially those that have informed global research 
ethics guidelines and practices.  
 
2.2  Scandals and tragedies in medical experiments 
There are many scandals and tragedies that have occurred in medical research including in Malawi. Some of 
the notable ones are discussed below. 
 
2.2.1  Nuremburg trials of Nazi war crimes 
After World War II, the Allies brought charges at Nuremburg against twenty-three Nazi doctors and 
bureaucrats for using thousands of concentration camp prisoners in experiments that challenged the 
legitimacy of human experimentation. As described by Faden, Lederer and Moreno (1996), some of the 
experiments done were as follows: putting the prisoners into low-pressure tanks to see how long they could 
survive; prisoners were infected with malaria and then given anti-malaria drugs; prisoners were given poison 
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in their food - most of them died immediately and those who did not die were killed for the purposes of 
autopsy; prisoners were burned with phosphorus material from bombs so that doctors could examine the 
wounds. In the court judgment, ten conditions were laid down that must be fulfilled in future health research 
involving human volunteers, generally referred as the Nuremberg Code (Amdur, 2011 p. 8).  The guidelines 
in the code emphasise the importance of voluntariness and informed consent (Amdur, 2011, p. 8). 
 
2.2.2  Brooklyn Jewish Chronic Disease Hospital study (1963) 
Two physicians from Brooklyn Jewish Chronic Disease Hospital in the United States of America (USA) 
performed this cancer research in 1963 (Emanuel et al., 2003). As described by the authors (Emanuel et al., 
2003) the aim was to determine the rate of rejection of human cancer cells injected into patients. The study 
procedures involved injecting living cancer cells into elderly patients without their full informed consent. The 
study results provided important evidence in terms of cancer treatment. The findings showed cancer cells 
would cause an immune reaction that would lead to expulsion from the body. A New York court brought 
charges against the two physicians. It was argued that although non-disclosure in the physician-patient 
relationship can be justified, non-disclosure in a researcher-participant relationship is unacceptable. A lesson 
learned from this incident is that a physician-researcher might have conflicting loyalties that are of ethical 
importance (Emanuel et al., 2003).  
 
2.2.3  Willowbrook study (1955-1971) 
This study sought to find methods for preventing hepatitis that was endemic at a state facility in New York. 
Emanuel et al. (2003) narrate that the researchers used disabled children and adolescents in the trial. The 
study procedures involved deliberately exposing them to hepatitis. The researchers hypothesised that by 
exposing incoming (new) patients to the hepatitis virus and then injecting them with protective antibodies, 
they would have slim chances of developing symptoms associated with more serious cases of hepatitis and 
would ultimately become immune to the virus. However, the conditions under which participants were 
recruited were coercive. The health facility was full but the researcher mailed parents of children who were 
on the waiting list that their children could be admitted into the institution only if they accepted a placement 
in the research ward from where they could be transferred into the facility. Study findings showed that, from 
the time this research was initiated, the rates of hepatitis declined. The researchers were also criticised for 
using intellectually handicapped children (Emanuel et al., 2003).  
 
2.2.4  Tuskegee syphilis study (1932-1972) 
Only a year after the Willowbrook scandal, more revelations on human rights violations were brought to the 
public about the Tuskegee syphilis study (Reverby, 2000). As narrated by Amdur (2003), there was a need to 
describe disease progression of syphilis. Therefore, researchers proposed a case-control study involving 300 
cases and 200 controls to examine effects of syphilis. In 1932 the researchers received sponsorship from the 
US Public Health Service to conduct this trial. There is no record to show if informed consent was obtained. 
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In 1950, participants were not informed nor given treatment when penicillin, an effective new treatment 
became available. It was thought the treatment would undermine the scientific purpose of the study. Many 
participants died of advanced sequelae of untreated syphilis. After public exposure, the study was stopped 
in 1972 and the US government apologised to study participants and their families and this led to the 
development of the National Research Act in 1974 (Amdur, 2011 p. 15). 
 
2.2.5  Guatemalan Study 
As narrated by Reverby (2012), there was a motivation to learn about the effectiveness of penicillin, as such 
the US National Institutes of Health sponsored a study which was conducted in Guatemala from 1946 to 1948. 
The purpose of this study primarily was to see if penicillin, as a newly available drug, could serve not just as 
a cure for early syphilis, but also as a prophylaxis for several STDs (Reverby, 2012). The study population 
included 1,500 Guatemalan orphans, soldiers, mental health patients, prisoners and sex workers. Confirmed 
records indicate that participants did not give their consent. The study procedures involved deliberately 
infecting participants with syphilis and gonorrhoea or the participants were coaxed to have sex with 
commercial sex workers who had a syphilis infection. If a participant failed to present symptoms of the 
infections, some had bacteria rubbed into scrapes on their penises, faces and arms (Reverby, 2012). Besides 
the unacceptable research standards in the trial, records show that academic institutions and government 
agencies in the US were aware of the study but their priority was to learn the study outcomes. While making 
investigations about a physician named John C. Cutler who was a researcher in the syphilis study in Tuskegee 
in the 1950s, Reverby discovered reports about this Guatemalan study which the public was not aware of 
(Reverby, 2012). Later, Reverby published her discoveries. A commission of the US government was instituted 
to find out the details of the Guatemalan study. The report prompted President Obama to apologize to the 
Guatemalan government and people for the U.S. sponsored trial that undermined participants’ rights and 
welfare in pursuit for knowledge.  
 
2.2.6  Malawi research scandal at St. Luke’s Hospital: The cancer clinical trial 
Despite the establishment of Malawian RECs, the country’s research oversight system had a rude awakening 
in 2008 when news emerged of study results from a cancer drug trial that was never approved by any 
Malawian REC. The researcher was a medical technician from St Luke’s Hospital in Zomba. Mkoka (2008) 
narrates that in 2006, he applied for ethics review of his research protocol at a Malawian REC. The REC raised 
a concern that the applicant was not sufficiently qualified to conduct the trial so he should involve an 
oncologist.   The applicant failed to address the concern and he resubmitted the same protocol to another 
Malawian REC that did not approve the trial. The applicant was not satisfied with the responses from the 
REC, so he submitted the research protocol to a department that oversees HIV implementation in the country 
under the Ministry of Health (MoH).  He didn’t receive feedback from Ministry of Health (Mkoka, 2008). 
Regardless of the lack of ethics clearance from any Malawian REC, the researcher reportedly began recruiting 
study participants. The trial sought to assess the safety and efficacy of a new treatment combination for 
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cancer patients. Twenty participants were recruited. The study population included very sick patients who 
had tumours and were in the final stages of HIV/AIDS according to World Health Organisation (WHO) staging 
(World Health Organisation, 2003). There were two study arms, whereby ten participants were randomised 
to each arm. Overall, there were six deaths from one study arm. Preliminary findings were released in 2008. 
The hospital administration was surprised by the study findings and inquired if there was any ethics clearance. 
The National REC was notified and members of this REC visited the research site to investigate, but they failed 
to verify whether informed consent was obtained and did not find patient files. However, the researcher 
confirmed that he conducted the trial. According to Malawi pharmacy guidelines, only oncologists are 
allowed to prescribe the cancer drugs used in this trial (Pharmacy Medicine and Poisons Board Act, 1988). 
Zomba court brought charges against the researcher. The case was contested in court. Eventually the accused 
was acquitted (Mkoka, 2008). Later, an appeal was submitted by the Pharmacy and Poisons Board but the 
accused was no longer living in Malawi and could not be traced.  
 
This section has attempted to provide examples of the history of research abuses that led to the 
development of research ethics guidelines that are outlined in the following section. 
 
2.3 Introduction of guidelines and ethical codes for researchers 
Most guidelines and ethical codes for research were developed to respond to a tragedy or scandal that 
occurred (Emanuel et al., 2003). Several guidelines have been published since World War II, all aiming to 
codify the rules that should govern the conduct of research. The sections below present selected important 
guidelines. 
 
2.3.1  The Nuremberg Code 
 The presiding judge of the Nuremberg trial presented ten conditions that must be fulfilled in research, 
including the provision that voluntary informed consent is absolutely essential (Amdur, 2011). Despite many 
researchers agreeing to the principles in his ruling, some researchers later complained that it was too 
restrictive in terms of persons who could not provide consent to research; for example, it meant that studies 
involving children could not be conducted (Emanuel et al., 2003). Further, there was a concern that the 
Nuremberg code which was developed at the end of the Nazi doctors’ trial in 1947 had some clauses that 
were very hard to understand. For instance, human experiments “should not be random and unnecessary in 
nature” (Nuremberg Code, Guideline no.2) yet there are some important medical breakthroughs such as 
anaesthesia, X-rays, and penicillin that were a result of random experimentation (Emanuel et al., 2003). 
Doctors thought the code was inadequate.  
 
2.3.2  Declaration of Helsinki 
The World Medical Association (WMA), a medical practitioners’ grouping, developed guidelines which 
received widespread approval in the United States. The guidelines stated that physicians are required to 
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obtain consent from patient-subjects unless it was not ‘consistent with patient psychology,’ and there was 
an allowance for surrogate consent if approved by a REC. Emphasis was made that clinical research involving 
human volunteers  cannot be conducted in the absence of the person’s free consent after being fully 
informed. Here it was also stated that all biomedical research studies involving humans must be reviewed by 
an independent REC. The declaration was received as a more practical guide to the conduct of ethical 
research than the Nuremberg code since it offered rules that are closely related to clinical settings rather 
than the idealised language of the Nuremberg Code (Emanuel et al., 2003). The WMA general assembly 
adopted the guideline in 1964 in Helsinki, but the most recent amendment occurred in 2013 (WMA, 2013). 
 
2.3.3  The Belmont Report 
Reflecting on past injustices, some investigators felt the rules and instructions that were already in place did 
not offer adequate safeguards to address exploitation and abuse of humans in research (Emanuel et al., 
2003). The rules were not fit to address complex situations case by case (Emanuel et al., 2003). Therefore, 
there was a need to develop principles relevant to research involving humans (Emanuel et al., 2003). The 
principles provided an ethical framework that would guide the resolution of ethical dilemmas arising from 
research. In 1979 a special committee was established and it eventually developed a report known as the 
Belmont Report; Ethical Principles and Guidelines for the Protection of Human Subjects of Research, Report 
of the National Commission for the Protection of Human Subjects of Biomedical and Behavioural Research. In 
the report they came up with three main principles: respect for persons, beneficence, and justice (Belmont 
Report, 1979). Firstly, the principle of respect for persons implies that a human being is an autonomous agent 
and those with diminished autonomy must be protected. Secondly, the principle of beneficence entails the 
need to confer benefit and protect humans from harm and making efforts to secure the well-being of 
humans, while the third principle of justice addressed fairness in the distribution of the benefits and burdens 
of research (Belmont Report, 1979). 
 
2.3.4 The Common Rule: Title 45, Code of Federal Regulations 46  
The Office of Human Research Protections (OHRP) in the US is mandated to guide researchers and IRBs/RECs 
to ensure the rights, welfare and wellbeing of participants in US federally funded research are protected. The 
OHRP enforces Federal Policy according to 45 CFR 46 and subpart A is referred as the Common Rule. The 
Common Rule was originally promulgated in 1991 but keeps being revised to enable it to meet challenges of 
the rapidly changing landscape of research.  The issues addressed are mainly institutional assurance, IRB 
review and Informed consent. Institutions conducting research involving human volunteers are obliged to 
comply with the Common Rule. The rule is clear that research protocols must be reviewed and approved by 
an independent IRB before commencement of the study and it also guides the operations of an IRB. 
Additionally, this rule has detailed guidance on issues to do with obtaining informed consent. Cleaton-Jones 
and Wassenaar, (2010) have compared the Common Rule and South African national guidance and laws. It 
showed that South African guidance is more stringent than the then extant US Common Rule.  
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2.3.5  Council for International Organisations of Medical Sciences (CIOMS) 
The Council for International Organisations of Medical Sciences (CIOMS) is an international non-
governmental organisation based in Geneva. The organisation was formed in 1949 and is a partnership 
between the World Health Organisation (WHO) and the United Nations Educational, Scientific and Cultural 
Organisation (UNESCO). CIOMS is involved in many ways of supporting improved ethical standards and review 
processes for research.  The aim is to provide guidance on health related research in three areas: Bioethics, 
pharmacovigilance and product development.  A revision of CIOMS ethics guidelines for health related 
involving humans was published in 2016 (CIOMS, 2016).    
 
2.3.6   The International Council for Harmonisation-Guideline for Good Clinical Practice ICH-GCP Guideline) 
The increase in international guidelines resulted in varying requirements that researchers and sponsors had 
to fulfil (ICH-GCP Guidelines, 1996). There was also an increase in international multi-centre clinical drug 
trials. In this case the need to harmonise regulatory requirements for the development of pharmaceutical 
products emerged (ICH-GCP, 1996). Thus in 1996 the United States, the European Union and Japan initiated 
the process of harmonising their drug trial guidelines leading to Good clinical practice (GCP) (ICH-GCP, 1996). 
An effort was made to avoid duplication of studies by making data generated from trials in one country 
acceptable in other countries. The approach aimed to accelerate drug development process. 
 
 RECs use these international guidance to ensure ethical implementation of research. Malawi has also 
benefited from these international standards. 
 
2.4.  Research Ethics Review in African Settings 
The international guidance documents described above have significantly influenced African research ethics 
standards (Kass et al., 2007). Some African RECs are using the US IRB system as an exemplar in their 
operations while others are in accordance with the World Health Organisation (WHO) guidelines (Ndebele et 
al., 2014).  It is widely recognised that low income settings pose unique ethical challenges in research 
involving human participation. These international guidelines nevertheless support the review of protocols 
in low income settings.  
 
Despite agreement on the principles of research ethics, there are variations in their application (Emanuel et 
al., 2008). Hyder et al. (2004) compared ethics reviews between a sponsor REC and a host REC, and found 
significant differences. According to these authors (Hyder et al., 2004), the sponsor RECs frequently raised 
issues regarding gate keepers permission, informed consent and selection of control arm, while the host RECs 
frequently raised issues relating to cultural appropriateness of the study followed by the relevance of 
research to the host country, the informed consent and availability of intervention (if successful).  Similarly, 
two case studies by Mfutso-Bengo and Taylor (2002) and Love and Fost (2003) also reported differences 
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between host and sponsoring country RECs.  Although there are differences, Mzayek and Resnik (2010) 
cautioned that it could be because the members of RECs hosting the research are strongly influenced by their 
own culture and sometimes coupled with the lack of training in ethical principles of biomedical research, 
unknowingly they may inject their own values into study protocol and procedures, eventually engaging in a 
kind of ethical relativism where local norms take precedence over universal ethical principles.  However, 
Mzayek and Resnik (2010) also point out that members should not subscribe entirely to western ethical 
norms because they may end up approving a study that is legally valid, but ethically inappropriate. 
 
Meanwhile, improving the capacity of African ethics review systems remains crucial. An early report by 
Nuffield Council on Bioethics raised concerns that RECs in developing countries may not adequately promote 
high ethical standards because they are poorly funded and lacked proper trained staff (Nuffield Council on 
Bioethics, 2002). Indeed, a survey by African Malaria Network Trust (AMANET) in 2007 revealed that that 8 
RECs out of 27 lacked SOPs; 10 RECs out of 28 lacked training of members on joining; 15 out of 28 lacked 
continuing training of members (Ndebele et al., 2014).  There has since been much progress. Ndebele et al. 
(2014) list the considerable past and ongoing training outputs in Africa over the past 15 years, including 
funded training by organisations committed to build African ethics review capacity such as African Malaria 
Network Trust (AMANET), European and Developing Countries Clinical Trials Partnership (EDCTP), Welcome 
Trust UK and the Fogarty International Centre.  
A brief discussion of the Malawi ethics review system follows below. 
 
2.4.1   Research oversight system in Malawi  
The legislation in Malawi has a provision to avoid abuses during the conduct of research involving human 
beings. Section 19 subsection 5 of the Constitution of Malawi states that no person shall be subjected to 
medical or scientific experiment without his/her consent (Constitution of the Republic of Malawi, 1996). In 
addition, through an Act of Parliament, the National Commission for Science and Technology (NCST) was 
established to coordinate and promote research in Malawi and to ensure that all research involving human 
beings is subjected to research ethics committee review (National Policy Measures and Requirements for the 
Improvement of Health Research Coordination in Malawi, 2012). The NCST has the mandate to establish 
RECs. According to the 2012 National Policy Measures and Requirements for the Improvement of Health 
Research Coordination in Malawi, Malawi has two RECs, the NHSRC established in 1988 and COMREC, 
established in 1996. Furthermore, in one of the email conversation with the personnel working at the 
National Commission for Science and Technology, the researcher of the present study was informed that 
there is a third REC known as and the National Committee on Research in the Social Sciences and Humanities 
(NCRSH) (Kachedwa, personal communication, April 7, 2017).   
 
Mfutso-Bengo et al. (2014) reports that documents like the Declaration of Helsinki, CIOMS, Belmont Report, 
Common Rule and ICH-GCP provide guidance for the operations of Malawian RECs. To help guide reviewers 
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of protocols, the RECs have a template which a reviewer uses, see Appendix VII. It is the duty of the REC to 
develop SOPs outlining how the review processes ought to be done. 
  
Besides the aforementioned RECs, the Pharmacy Medicines and Poisons Board (PMPB) has the mandate to 
regulate the pharmaceutical industry in Malawi and to complement the role of RECs (Pharmacy, Medicine 
and Poisons Board Act, 1988). The PMPB issues product licenses for clinical trial-related products. Since 2008, 
soon after the St Luke cancer trial scandal, the NHSRC and PMPB have conducted joint review of vaccine and 
drug development clinical trials (Mkoka, 2008). 
  
2.5 The Emanuel et al. (2008) framework  
Studies have shown that different RECs reach different conclusions when reviewing the same research 
protocol (Hirshon, Krugman, Witting, Furuno & Limcangco, 2002; Silverman, Hull, Sugarman, 2001; Stair et 
al., 2001). Furthermore, researchers have complained and criticised RECs for being dysfunctional (Fost & 
Levine, 2007), overburdened (Burman, Reves, Cohn, & Schooley, 2001), and over-reaching (Gunsalus et al., 
2006), irrational, incompetent, and inconsistent in decision-making (Edwards, Ashcroft, & Kirchin, 2004; 
Hannigan & Allen, 2003; Lux, Edwards, & Osborne, 2000).  To help RECs, Emanuel and colleagues in 2000, 
2004 and 2008 analysed key international ethics codes and produced a framework made up of eight principles 
and benchmarks to provide a unified and consistent ethical guideline for reviewing biomedical research. 
According to the ethical framework, studies should be assessed to ensure that there are collaborative 
partnership, social value, scientific validity, fair participant selection, and a favourable risk-benefit ratio 
(Emanuel et al., 2004; 2008). According to the framework, it is presumed that studies must also undergo 
independent ethics review, have informed consent, and be able to demonstrate ongoing respect for 
participants. The Emanuel et al. (2008) framework is summarised below and Table 1 shows the principles and 
their benchmarks. 
 
1. Collaborative partnership requires the involvement and contributions of the host community. The 
partnership includes shared responsibilities as well as research benefits, and when conducting the study, the 
values and needs of the host community must be respected.  
2. Social value is a principle that ensures that the proposed research has the potential to generate 
knowledge to benefit the participants, community, society, and research community or health system, 
without any wastage of resources. 
3.  Scientific validity ensures that the proposed research is using reliable and valid research designs and 
methods to obtain data, and is relevant to the objectives. The results from the study must be applicable to 
the health problem being studied. In addition, the researchers ought to be appropriately qualified. 
4.  Fair participant selection entails the need to appropriately choose a study population that is relevant 
to the research objectives.  
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5.  A favourable risk-benefit ratio firstly ensures the identification and minimisation of all forms of 
potential harms to participants in terms of nature, size, and its likelihood. Secondly, the identification, 
quantification and maximisation of possible benefits should be considered. Thirdly, there is need to balance 
the potential risks and benefits among the participants and society. 
6.  Independent ethics review requires the REC to be independent from external influence and should 
be guided by law and have and follow documented standard operating procedures.  The review process must 
be transparent to ensure justified decisions. RECs should be fair at handling multiple reviews.  
7. The principle of Informed consent ensures that the research recruitment procedures and incentives 
involved must be appropriate to the local setting and that disclosure documents and procedures are tailored 
to respect the participants’ local context. Informed consent requires disclosure of complete, accurate, and 
adequate information to participants; there is also provision for obtaining surrogate consent, if required; 
provision for obtaining permissions from relevant gatekeepers; and clearly informing the participants of their 
right to participate, refuse, or withdraw from research.  
8. Ongoing respect for participants requires monitoring of the health status of participants and 
minimising risks and upholding confidentiality. Even when participants decide to withdraw from the study 
they may not be deprived of effective health care services, and the researchers must have plans for 
dissemination of research findings and post-research obligations. 
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Table 1: The eight principles and benchmarks, reproduced from Emanuel et al. (2008)  
Principle  Benchmarks 
Collaborative 
partnership  
Develop partnerships with researchers, makers of health policies, and the community. 
Involve partners in sharing responsibilities for determining the importance of health problem; 
assessing the value of research; planning, conducting, and overseeing research; and integrating 
research into the health-care system.  
Respect the community’s values, culture, traditions, and social practices. 
Develop the capacity for researchers, makers of health policies, and the community to become full and 
equal partners in the research enterprise. 
Ensure that recruited participants and communities receive benefits from the conduct and results of 
research.  
Share fairly in financial and other rewards of the research. 
Social value 
Specify the beneficiaries of the research. 
Assess the importance of the health problems being investigated and the prospective value of the 
research for each of the beneficiaries. 
Enhance the value of the research for each of the beneficiaries through dissemination of knowledge, 
product development, long-term research collaboration, and/or health system improvements. 
Prevent supplanting the extant health system infrastructure and services. 
Scientific 
validity 
Ensure that the scientific design of the research realizes social value for the primary beneficiaries of the 
research. 
Ensure that the scientific design realizes the scientific objectives while guaranteeing research 
participants the health-care interventions to which they are entitled. 
Ensure that the research study is feasible within the social, political, and cultural context or with 
sustainable improvements in the local health-care and physical infrastructure. 
Fair selection 
of study 
population 
Select the study population to ensure the scientific validity of the research. 
Select the study population to minimize the risks of the research and enhance other principles, 
especially collaborative partnership and social value. 
Identify and protect vulnerable populations. 
Favorable 
risk-benefit 
ratio 
Assess the potential risks and benefits of the research to the study population in the context of its 
health risks. 
Assess the risk-benefit ratio by comparing the net risks of the research project with the potential 
benefits derived from collaborative partnership, social value, and respect for study populations. 
Independent 
review 
Ensure public accountability through reviews mandated by laws and regulations. 
Ensure public accountability through transparency and reviews by other international and non-
governmental bodies, as appropriate. 
Ensure the independence and competence of the reviews. 
 Informed 
consent 
Involve the community in establishing recruitment procedures and incentives. 
Disclose information in culturally and linguistically appropriate formats. 
Implement supplementary community and familial consent procedures, where culturally appropriate. 
Obtain consent in culturally and linguistically appropriate formats. 
Ensure the freedom to refuse participation or withdraw. 
Respect for 
recruited 
participants 
and study 
communities 
Develop and implement procedures to protect the confidentiality of recruited and enrolled 
participants. 
Ensure that participants know they can withdraw without penalty. 
Provide enrolled participants with information that arises in the course of the research study. 
Monitor and develop interventions for medical conditions, including research-related injuries, for 
enrolled participants, at a level at least as good as existing local norms. 
Inform participants and the study community of the results of the research. 
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2.5.1 The relevance of the Emanuel at al. (2008) framework 
Many authors have cited the Emanuel framework and it is commonly used in research ethics training. This 
framework is often used to review both published and proposed research (Budin-Ljosne, 2012; Fakruddin, 
Chowdhury, Hossain, & Mannan, 2012; Miller & Brody, 2003; Miller & Shorr, 2002; Shaw & Elger, 2013; Union 
Graduate College & Vilnius University, 2012; Wassenaar, 2006). It has also been adapted for use in reviewing 
social science research (Wassenaar & Mamotte, 2012).  
In 2002 Miller and Shorr used the seven principles of an earlier (Emanuel et al., 2000) version of the Emanuel 
et al. (2004, 2008) framework to illuminate ethical issues posed in an industry-sponsored trial concerning an 
asthma drug in the USA. Following the framework’s guidance, the authors managed to raise several serious 
ethical problems about the drug trial. Later in their article the authors called the framework a valuable tool 
for REC/IRB members in reviewing research protocols (Miller & Shorr 2002). Similarly, in 2012 Farkruddin and 
colleagues published an article highlighting the need to develop ethics guidelines for the conduct of health 
research in Bangladesh. They reported that most studies in Bangladesh were not being published in reputable 
journals because they failed to satisfy the requirement for Independent ethical review. In the article the 
authors managed to list principles that should be considered when developing Bangladesh guidelines for 
ethical review of research proposals. All principles and benchmarks proposed by Emanuel et al. (2004) were 
included. In 2016 Mfutso-Bengo (2016) reported a study to understand the decision-making process of 
Malawian women who participated in clinical trials. He found that participants were able to differentiate 
between clinical research and clinical care. The women reported that they chose to participate in clinical 
research in order to access better health care and not for generalisable knowledge. Mfutso-Bengo raised 
some ethical questions;  
“Is it reasonable to join research in order to get good care? What is the difference between a 
researcher who joins a research team for the sake of desire to publish [to advance his/her career] 
and the research participant who joins a study with a desire to get better medical care? Are both 
decisions rational?” (Mfutso-Bengo, 2016, p. 13)   
However, Mfutso-Bengo (2016) argues that if a study conducted in a limited resource setting can satisfy the 
requirements proposed by the Emanuel et al. (2004; 2008) framework, those ethical questions automatically 
gets resolved. In South Africa, Tsoka-Gwegweni and Wassenaar (2014) reported concerns raised by a South 
African REC to determine whether their concerns could be accommodated in the proposed framework by 
Emanuel and colleagues (2008). The findings are reported in the following section.  
 
2.5.2 A review of the Tsoka-Gwegweni and Wassenar (2014) study  
The present study is a replication of Tsoka-Gwegweni and Wassenaar’s (2014) study. Their study used the 
eight principles of the Emanuel et al. framework (2004) to review the minutes (2008-2012) of a South African 
Biomedical REC (Tsoka-Gwegweni and Wassenaar, 2014). They found that there were 1043 queries raised by 
the REC. Of these, 99.7% of the queries were accommodated by the Emanuel framework. The most frequent 
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concern was about informed consent followed by scientific validity. Informed consent queries covered the 
biggest percentage (27.4%) of the 1043 concerns raised; issues like appropriate disclosures, documents, and 
processes, the language used, research setting, and completeness of the essential information given to 
participants, presentation and truthfulness of information, applicability of recruitment methods and 
incentives to local context, site gatekeepers’ permission, respect for autonomy, and context of consent 
process. These findings correlate with the vast literature showing how informed consent plays a dominant 
role in research. Since the 1940s, it has become a key principle of the Nuremberg Code and was adopted by 
the Declaration of Helsinki in 1946. For many years, it was marked as an obligation for a researcher to obtain 
informed consent; however, the focus has shifted from researchers’ obligation to disclose information to a 
focus on the quality of participants’ understanding the consent (Beauchamp & Childress, 2013).  
 
Scientific validity ranked second (21.4%) in the Tsoka-Gwegweni and Wassenaar (2014) study. Research that 
is not sound scientifically is harmful and shows a lack of respect for participants because the study results 
cannot be trusted and because it would be wasting participants’ time and other resources.  This study was 
the first of its kind to rank the REC queries from protocol review minutes using the Emanuel et al framework 
(2004). The findings from the present study will also be used to compare the SA findings. 
 
2.6 Empirical studies on Research Ethics Committee Operations 
Studies on RECs are relatively rare. Evaluating RECs may be challenging, but their operations ought to be 
assessed (Fernandez Lynch, 2018). It is standard practice for members of the REC to conduct protocol review 
in closed meetings and their minutes are confidential. RECs communicate to the investigators the reasons 
why the REC has made a particular decision. The Declaration of Helsinki (2013) highlights the need for RECs’ 
transparency and accountability. The REC letters are required to give justifications. A study by Clapp et al. 
(2017) found that a significant number of letters from UK RECs rarely cite the regulations as justification for 
the suggested/proposed changes to the investigators. In addition, Dixon-Woods et al. (2007; 2008) found 
that RECs often use ‘authoritative tone’ in their correspondence with investigators even on an issue where 
there is significant debate in the bioethics community. Gunsalus et al. (2006) reported that in the American 
context IRBs have been accused of ‘mission creep’ because they are crossing a line beyond their ethico-
regulatory authority. 
Regardless of the challenges identified in the above studies, Clapp et al. (2017) found that RECs raise issues 
of informed consent with greatest frequency, followed by study designs, even when protocols have been 
peer reviewed. A study by Humphreys et al. (2014) who interviewed REC members, described that members 
felt that participant safety and ethical factors could only be deemed appropriately addressed if the study 
methods were scientifically sound. Sound design was seen as necessary for approval of a research protocol. 
Elsewhere, queries relating to study design were common in investigator-initiated studies with non-physical 
procedures, while fewer queries were raised when evaluating clinical drug trial protocols (Happo, Alkoaho, 
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Lehto, & Karanen, 2016) suggesting that in drug trials, there is considerable investment made by drug 
companies to ensure positive peer review.  
There is evidence of increasing efforts to improve research ethics capacity in developing countries. Ndebele 
et al. (2014) reports initiatives for capacity building in the past fifteen years, but the authors mentioned 
that the increasing amount and complexity of health research being conducted in Sub-Saharan Africa 
suggests the need for continued investment in research ethics capacity development. The present study 
follows the cited empirical studies to examine ethical issues raised by an African REC because they can also 
be used to inform further training of REC members and support ongoing efforts of improving ethical oversight 
in Malawi and possibly in Africa more generally. 
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CHAPTER 3: RATIONALE OF THE STUDY 
 
3.1  Introduction 
To date, there is limited empirical evidence of what ethical issues are raised by RECs in developing countries 
(Silaigwana & Wassenaar, 2015, 2019). Mostly, the evidence is anecdotal, and sometimes develops from the 
practical difficulties that investigators experienced while seeking ethics clearance (Dixon-Woods, Angell, 
Ashcroft, & Bryman, 2007). Empirical evidence is important to inform policies and guidance documents. To 
the best of our knowledge, there has not been an empirical study to identify ethical issues commonly raised 
by Malawian RECs. This study sought to fill the gap. 
 
Given the poverty, limited health care services, illiteracy, cultural and linguistic differences, and limited 
understanding of the nature of scientific research, the weight given to particular ethical principles during 
review of health research by RECs may differ. A recent paper (Tsoka-Gwegweni & Wassenaar, 2014) presents 
findings for a South African REC but there are no other data with which to compare such findings. A closer 
and systematic examination of the ethical issues raised by a Malawian REC may shed more light on this 
question, comparatively. It will also consider the applicability of the Emanuel et al. (2004) framework to an 
African context because this study forms part of a broader multi-national study taking place in Ghana, South 
Africa, Cameroon, Nigeria, and Zimbabwe. 
 
3.2  Aims of the study 
The study aimed firstly to identify the main ethical issues raised during ethics review of research proposals 
submitted to a Malawian REC and secondly to assess their relative weight using Emanuel et al.’s (2004, 2008) 
principles and benchmarks of ethical review of clinical research. 
 
The overarching questions are as follows; 
1) What ethical concerns does a REC in Malawi raise when reviewing protocols? 
2) Is there a systematic prioritisation of some ethical issues over others?  
3) Is there an observable pattern to the ethical concerns raised by committee members? If so, what is 
the pattern?  
4) Are the concerns raised consistent with the framework developed by Emanuel et al. (2004, 2008)?  
5) Does any feature of the Emanuel et al. (2004, 2008) framework dominate the concerns? If so, which 
one?  
6) Are there other concerns raised by the REC which are not consistent with the framework discussed 
by Emanuel et al. (2004, 2008)?  
  
3.3  Specific objectives 
The specific objectives of this study were: 
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1. to identify and describe the pattern of ethical concerns and issues raised in reviews of research 
proposals.  
2. to analyse and rank the ethical issues and concerns raised by the REC using Emanuel et al.’s (2004, 
2008) framework and to determine whether they do or do not fit the framework. 
 
The methodology used is presented in the next section. 
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CHAPTER 4: RESEARCH METHODOLOGY 
 
4.1  Research design 
This research consisted of a case study based on content analysis of archived written documents, which were 
the minutes of protocol review meetings of a Malawian REC. As described by Yin (2013), a case study is an 
empirical approach that is used mostly by a researcher whose goal is to answer ‘how’ or ‘why’ questions 
about an existing issue (the case). The case study design was suitable to identify ethical issues raised by a REC 
and understand how they relate to the principles and benchmarks of the Emanuel et al. framework (2004, 
2008). Here, the plan was to test whether the concerns raised by one Malawian REC during protocol review 
do or do not fit this framework. This study does not attempt to answer the ‘why’ question, however. 
Additionally, qualitative research methods were employed by conducting a content analysis. As described by 
Hsieh and Shannon (2005), content analysis starts with theory and findings from prior studies which then 
guide the initial codes. Therefore, the codes for the present research were derived from Emanuel et al. (2004, 
2008) framework. This research is part of an international collaboration involving the 2013 and 2015 South 
African Research Ethics Initiative (SARETI) Master’s degree students from the University of KwaZulu-Natal 
(UKZN), South Africa. In Malawi two RECs are under study while other countries include Ghana, Nigeria, 
Zimbabwe, Uganda, and South Africa.  This report covers the findings from one Malawian REC. Partners will 
research and present findings from individual RECs, this research will eventually be compiled into an 
international group report.  
 
4.2  Sampling method 
For this study to be able to contribute to the international group project, a standard methodology and 
analytic framework had to be adopted across all countries. As such, minutes from all participating countries 
should ideally have covered the same period. The minutes for a period of two years (2012-2013) were 
selected. However, the 2012 minutes for the REC were missing; thus the protocol was formally amended to 
include the 2013-2014 minutes of the REC under study.  
 
The sample size was not pre-specified because it depended on the workload of the REC within the specified 
study period. These minutes provided the ethics feedback that applicants received. Considering that the REC 
under study had 11 scheduled meetings per year, 22 sets of minutes for this period of review were expected. 
Only recorded minutes of all newly submitted full review protocols were included in this study, without any 
consideration of the type of study (clinical trial, social research, biomedical, or behavioural study). The sample 
excluded expedited and continuing reviews, annual reports, undergraduate studies, and study final reports.  
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4.3  Study setting 
The membership of the REC under study has representation from other Malawian RECs and a lay member 
representing the community. The REC is composed of members from various disciplines but major categories 
are biomedical sciences, research methods (epidemiology and biostatistics), behavioural sciences, and 
bioethics. The composition also considers gender equity and the maximum number of members is fifteen.  
Duration of member appointment is three years but this is managed in a way to promote institutional 
memory and good succession. The REC guidelines also state that members can only serve two consecutive 
terms.  
 
The REC has a secretariat. There is a requirement that new members undergo research ethics training which 
covers the following: Functions and operations of a REC; research guidelines; how to conduct scientific and 
ethical review of protocols; and good research practice. According to the REC’s standard operating 
procedures (SOPs), all members are required to declare potential conflicts of interest, if relevant, and must 
recuse themselves from deliberating and decision-making for that protocol.   
 
The REC has a list of external experts who can be engaged to act as independent reviewers in a specific area 
e.g.,  specific diseases or study methodologies, particular community, patients, and special interest groups 
which are not represented among the REC membership but  are applicable to a submitted research protocol. 
Whenever there is a need to engage an external expert to support the review process, the names of experts 
can only come from a standard list. This list is developed by the REC from the beginning of its term. The 
external expert is then informed and asked to submit a curriculum vitae. According to the SOP, external 
experts do not vote.  
 
The REC has a subcommittee on participant safety that reviews adverse events and provides 
recommendations to the REC. The REC has a system that helps to monitor approved research. In cases of 
misconduct a report is generated which is reviewed by the REC and an appropriate decision is made. If there 
is a need for termination of a clinical trial, the investigator is informed and the REC submits a notification to 
the Malawi Pharmacy and Poisons Board, the National Commission for Science and Technology and the trial 
sponsors.  
 
According to the REC SOPs, protocol submissions are received by the secretariat where administrative work 
including registration of applicants is done. All applicants are required to pay a standard fee for review and 
once the protocol is approved, the applicant pays 10% of the study budget. The secretariat verifies 
completeness of the application; if the application is incomplete, the applicants are informed within two 
working days. Principal investigators submit a full protocol plus a completed ethics application form for all 
new applications. Following this, the REC administrator assesses the risk level and decides which protocols 
can go for expedited review and which need full committee review. The chairperson and administrator then 
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assign primary and secondary reviewers based on expertise in the subject area of study. Secretariat personnel 
submit a package to reviewers by the tenth of every month.  
 
According to the review process SOP, reviewers must use a standard protocol assessment form to ensure a 
structured process. Reviewers must submit the completed protocol assessment forms (see appendix VII) to 
the secretariat seven days before the full REC meeting. The issues raised by these reviewers are then 
compiled on a standard form and distributed during the full REC review meeting. During REC meetings, the 
primary reviewer presents the protocol and members discuss issues arising. If all members agree, the 
protocol is approved by consensus and, if there is any disagreement, the chairperson calls for a vote and a 
decision is made based on a simple majority vote. According to their SOP, deliberation on one protocol may 
not exceed thirty minutes. The secretariat documents the proceedings and retains custody of 
correspondence with applicants. REC meetings are conducted on pre-announced dates, set at the beginning 
of each year. Finally, the outcomes of the reviews are communicated to applicants within seven days of the 
meeting date, in writing by letter. These letters are extracted from the relevant minutes. 
 
4.4  Data collection 
Data was collected in March 2017. Firstly, a staff member from the REC secretariat sent the minutes through 
email to a colleague who also has access to REC minutes. The colleague went through all the minutes received 
and removed identifiers such as names before sending them to the researcher. Once the minutes were made 
available to the researcher, they were reviewed to check if there were any missing sets or missing pages. Of 
the expected 22 sets of minutes, three sets were missing i.e., only 19 complete sets were received. The REC 
secretariat confirmed that three sets of minutes were missing.  
 
Each set of minutes contained a list of applications received and these were categorised as: new application, 
resubmission, student proposals, progress reports, and serious adverse events (SAEs). The study sample 
included new applications only.  
 
4.5  Data analysis 
Deductive content analysis (Babbie, 1998) was used to evaluate the recorded concerns. With this approach, 
the contents of the queries raised were analysed according to predesignated domains as per the principles 
and benchmarks of the Emanuel et al. (2008) framework. There was also a provision for an ‘other’ category 
to cater for issues that were not covered by the framework. Firstly, we assigned numbers to the principles 
and benchmarks (e.g. collaborative partnership was number 1 and the four benchmarks within this principle 
were 1a, 1b, 1c, and 1d, see Appendix VI). For each proposal, the concerns in the minutes were coded and 
the occurrence of the principles and benchmarks were recorded. Thus, the concerns from the minutes were 
converted to numbers assigned to a particular principle. Then the data were double entered into Microsoft 
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Excel (Redmond, Washington, USA).The Excel spreadsheets were convenient and provided tools for checking 
outliers using the filter command. Using simple descriptive univariate analysis, frequencies were generated 
and presented in table and graph format. This approach provided insight into how often the principles were 
raised. 
 
Independently, two people reviewed each set of the minutes. The researcher (myself) and a colleague who 
did the coding are both SARETI scholars (2015 and 2016 intake). Throughout the SARETI course work, the 
coders were trained to use the Emanuel framework (2004, 2008), so it provided the coders the necessary skill 
for coding the data. 
 
In the analysis, a particular concern occasionally required the use of more than one principle. In such cases 
we double-coded. In cases of disagreements on the application of certain principles, we were able to resolve 
this by reaching a consensus in our weekly meetings. 
 
4.6  Ethical considerations 
In this section, the Emanuel et al. framework (2008) is used to evaluate the present study. Firstly, this study 
has demonstrated collaborative partnership. This study was conceptualised by a professor of research ethics 
at the University of KwaZulu-Natal (UKZN) in South Africa, and the one implementing the study is his student 
from Malawi. Malawi’s only professor of Bioethics supported the study, (see Appendix II). At the end of the 
research process, it will be the duty of the student researcher to share the study findings with the Malawian 
REC.  
 
Secondly, this study has social value. It will generate evidence on the ethical issues commonly raised during 
REC review meetings, being the first such study to evaluate such issues in Malawi. Findings may be helpful to 
inform growing efforts to understand health research governance in the country.  
 
Thirdly, scientific validity has hopefully been addressed. There was a need for an in-depth investigation to 
test how the framework is applicable to a Malawian setting. The case study design was suited to understand 
the ‘how’ question (Yin, 2013). Additionally, the use of content analysis for archived documents was the only 
practical approach to obtaining reliable data for this type of study. The study protocol was developed and 
followed without any deviation. Experienced researchers, trained in good clinical practice (GCP) and SARETI 
scholars did the data abstraction and coding. The design is a replication of a study by Tsoka-Gwegweni and 
Wassenaar, (2014). 
 
The fourth principle in the framework is fair selection of the study population. In this study, we used minutes 
of meetings. Since this is a group project involving the 2013 and 2015 SARETI students, for our study to 
contribute to the project, we aimed at adopting a standard methodology and analytic framework including 
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studying minutes for a period of two years (2012-2013). However, because the Malawian REC secretariat was 
missing the 2012 minutes, therefore the 2013-2014 minutes were used. No human participants were 
involved. 
 
After appraising the risks and the benefits of the study, we acknowledged that REC minutes are confidential 
and that accessing and analysing them could appear as policing the work of the REC. Similarly, a breach of 
confidentiality is a major risk. Considering that Malawi has two RECs that review clinical research, even if we 
made an agreement stating that the name of the REC would not be printed in any publication of results, it 
would be difficult to prevent deductive identification. Nevertheless, the study was deemed beneficial; 
therefore, efforts to minimise unnecessary risk were employed by removing identifiers before the minutes 
were made available to the researcher.  The name of the REC under study will not be mentioned in any 
publication. Thus, we were able to attain a favourable risk-benefit ratio. 
 
The sixth principle in the framework is the independent review of the research protocol. We can confirm that 
this research has received ethics approval from two independent RECs that have federal-wide assurance 
(FWA) numbers. One is COMREC (Appendix III and IV) from Malawi, whose FWA number is 00011868, while 
the other is the UKZN Biomedical Research Ethics Committee (BREC) from South Africa (Appendix V), FWA 
number 678. Firstly, the protocol was submitted to the UKZN BREC and   provisional approval was granted on 
September 16, 2016. It stated that full approval would be issued only after obtaining Malawian ethics 
approval. The Malawian REC approved the study on December 1, 2016, and an amended approval was issued 
February 1, 2017. This amendment was done to change the study duration of minutes from 2012-2013 to 
2013-2014. The researcher then submitted the COMREC approvals to UKZN BREC and full approval was 
obtained on March 17, 2017 (BCA 342/16). 
 
The seventh principle to consider is informed consent. The nature of the study did not require individual 
informed consent. It just required the gatekeeper’s approval and this approval was obtained when the REC 
accepted the proposal to have the minutes studied by the researcher and ethics approval was issued. 
 
The eighth principle is respect for recruited participants and study communities. In this study, the REC 
chairperson will read the draft report to ensure that he accepts findings before wider dissemination of the 
results. The results will be shared with the REC in question. 
 
4.7  Validity, reliability, generalisability and reflexivity 
When evaluating the internal validity of a study, the key consideration is whether the conclusions from the 
findings follow from the data and the procedures used in this research. The researcher started by developing 
a study protocol which was approved by two RECs and then the researcher followed the research protocol 
without deviations. Two researchers independently coded the data throughout the analysis. The engagement 
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of a second coder was aimed at comparing and discussing the principles used, in an effort to reduce bias 
(Baxter & Jack, 2008).  
 
Reliability is generally understood to concern the replicability of research findings and whether or not they 
would be the same if another study using the same or similar methods was undertaken. In addition, Richie 
and Lewis (2003) report that there are some schools of thought which believe that qualitative research is 
dynamic and should only be conducted effectively in a responsive manner; however, they urge that such 
studies can never be, nor should be, repeated. Despite this reported line of thinking, this study sought to find 
ways of increasing reliability. In our case, confirmability and ‘trustworthiness’ will be considered (Richie & 
Lewis, 2003). Confirmability in the study was achieved by asking the chairperson of the REC being studied to 
review the final report before dissemination of the results (Baxter & Jack, 2008). Additionally, well-known 
Malawian REC members were consulted periodically throughout the research process. This consultation 
process hopefully makes the findings of this study trustworthy. 
 
Generalisability refers to the extent to which findings from a study apply to a wider population or to different 
contexts. As described by Green and Thorogood (2007), in a sample survey, random sampling is likely to be 
statistically representative of the larger population of interest, so findings can be extrapolated to that 
population. However, in our case, no random sampling was involved but purposive sampling was used to 
study the 2013 and 2014 minutes. Of the 22 meetings held, 19 sets of minutes were studied. In addition, 
generalisability from this type of sampling arises from conceptual transferability of the concepts generated 
rather than statistical representativeness of the sample (Green & Thorogood, 2007). The hope is that the 
findings from this study are helpful to the health research ethics community in Malawi. Considering that this 
is a relatively under-researched topic, generalisability may be less salient than that of ‘sensitising’ the 
research community (Green & Thorogood, 2007). Researchers may be sensitised to research ethics data 
relevant to the Malawian context. The present study is a replication of an existing design by Tsoka-Gwegweni 
and Wassenaar, (2014) which should enhance reliability and validity. 
 
Reflexivity is a process whereby the researcher considers how her own values, life experiences and 
assumptions have influenced the research (Pitard, 2017). In the present study the investigator is a Malawian 
who has worked as an IRB officer for three years at a biomedical research institution in the country. As an 
IRB officer, her role was to guide principal investigators on regulatory and ethical issues and respond to 
concerns raised by the Malawian RECs. Therefore the researcher was keen to learn the decision-making 
outcomes of the Malawian REC under study so as to identify training areas in her institution and also to find 
areas in which the REC can improved. Furthermore, Pitard (2017) states that the researcher also ought to 
consider the trustworthiness and rigour of research design and methodology. The investigator interacted 
with members of the REC secretariat and it was easy to consult occasionally in order to understand the 
contents of the minutes. These consultations were made to enhance trustworthiness of the study findings. 
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Overall, all the study procedures were followed without deviation to enable the researcher to move from 
research questions to its answers (Yin, 2013). The next chapter details the results of the study.  
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CHAPTER 5: RESULTS 
 
5.1  Introduction 
This chapter presents findings of the content analysis study that was done on the 2013 and 2014 minutes of 
REC protocol review meetings. The analysis excluded expedited and continuing reviews, resubmissions, 
protocol amendments, annual reports, study final reports, and any other reports. The findings are from the 
recorded minutes of newly submitted protocols during the study period.  
 
The results describes the ethical issues raised during review of proposals and the  ranking of ethical issues 
and concerns raised using Emanuel et al.’s (2004, 2008) framework to understand whether they do or do not 
fit the framework. However, the first section outlines a summary of the research protocols that were 
reviewed and received queries. 
 
5.2  Data summary 
A total of 139 protocols was submitted for ethics review. Of these, 3(2.1%) protocols received full approval 
on initial submission and 136 (97.8%) received various comments.  Of the 136 protocols that attracted 
comments, 52 were reviewed in 2013 and 84 were reviewed in 2014. Figures 1, 2 and 3 presents summaries 
of the study designs of the 136 protocols while Table 2 presents their areas of study. Fig 4 presents outcomes 
of the review meetings. 
 
 
Fig 1: Summary of protocols reviewed in 2013 and 2014 
 
 
 
 
 
 
2013
38.2%
2014
61.8%
Research Protocols by Year
2013 2014
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Fig 2: Study designs proposed in the reviewed research protocols 
 
 
Fig 3: Proposed research participants in the reviewed protocols 
 
Fig. 3 shows that, of the 136 protocols, 33.1% proposed research on adults, 18.4%  on children only, 
5.5% on both adults and children, and 37.5% had unknown participant demographics because these 
were not recorded in the minutes. Furthermore, 5.1% of protocols were listed as ‘not applicable’ 
because they used records or laboratory stored samples as their data source. Fig. 2 shows that 
among the reviewed protocols, 48.5% proposed a cross-sectional study design, while 37.5% were 
listed as unknown design because these were not recorded in the minutes. There were also 8.1% 
clinical trials, 4.4% cohort studies, and 1.5% case control studies.  
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Table 2: Summary of Proposed Study Area (N=136) 
Study Focus 
 
 
 Number 
of 
protocols 
Percentage 
Malaria 18 13.2% 
HIV 16 11.8% 
Reproductive health 12 8.8% 
Health system strengthening 10 7.4% 
Maternal and child health 7 5.1% 
Nutrition 6 4.4% 
TB 5 3.7% 
Cancer 4 2.9% 
Unknown 4 2.9% 
Diabetes 3 2.2% 
Disability 3 2.2% 
Eye 3 2.2% 
Haematology 3 2.2% 
HIV & Cancer 3 2.2% 
Nursing education 3 2.2% 
Pneumonia 3 2.2% 
Ear and hearing care 2 1.5% 
Epidemiology of diseases 2 1.5% 
Influenza 2 1.5% 
Rotavirus 2 1.5% 
Trauma 2 1.5% 
Amblyopia  1 0.7% 
Antibiotic use 1 0.7% 
Autism & Malaria 1 0.7% 
Bronchoscopy 1 0.7% 
Burns 1 0.7% 
Heart 1 0.7% 
Diarrhoea 1 0.7% 
Ethics  1 0.7% 
Family medicine 1 0.7% 
Family planning 1 0.7% 
HIV & Cardio-respiratory Disorders 1 0.7% 
HIV & Diabetes 1 0.7% 
HIV & Diabetes & Hypertension 1 0.7% 
Hygiene 1 0.7% 
Hypertensive Retinopathy 1 0.7% 
Kidney injury 1 0.7% 
Malaria & HIV 1 0.7% 
Medicine education 1 0.7% 
Health 1 0.7% 
Pharmacy education 1 0.7% 
Radio programme evaluation  1 0.7% 
Respiratory infection 1 0.7% 
Schistosomiasis 1 0.7% 
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Table 2 presents the area of study and it shows largest proportion of the proposals intended to study malaria 
(13.2%), then HIV (11.8%), and reproductive health (8.8%).  
 
 
Fig 4: Outcomes of protocol review (N=136) 
 
Figure 4 shows the final decision of the review process. There were very few protocols that the Malawian 
REC approved on initial submission. Likewise, there were very few protocols were rejected outright, 
although there was an increase of such rejections in 2014.  
 
5.3  Issues and Patterns of ethical concerns raised by a Malawian REC 
A total of 1,274 concerns were raised. Figure 1 shows the distribution of concerns using the Emanuel et al 
framework (2004, 2008) and other concerns that did not fit in the framework. The highest proportion of the 
concerns raised were issues concerning scientific validity (487; 38.2%), followed by informed consent (282; 
22.1%), and independent review (118; 9.3%). Then, issues concerning collaborative partnership (60; 4.7%), 
respect for participants (49; 3.8%), social value (47; 3.7%), favourable risk-benefit ratio (45; 3.5%), fair 
selection of participants (37; 2.9%) were also raised. Furthermore there were other concerns such as 
language errors (124; 9.7%) and inappropriate references/plagiarism (25; 2%) which are not part of the 
Emanuel et al framework (2004, 2008). 
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Figure 5: Pattern of queries raised by a Malawian REC in 2013 and 2014 (N=1,274) 
 
 
5.3.1 Comparison of patterns of ethical issues raised by a Malawian REC (N=1,274) and South African RECs 
(N=1,043)  
Although not a stated goal of this study, it was decided to compare the Malawian data with some South 
African findings that used the same methodology. Figure 5 shows findings from the present study and 
findings from the study by Tsoka-Gwegweni and Wassenaar (2014) in South Africa. The South African REC 
had informed consent (24.7%) and scientific validity (21%) covering the highest proportion of the concerns 
raised during review of research protocols; these are the same top two concerns from the Malawian REC 
but the ranking is different.  
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Figure 6: Graph comparing ethical concerns from a Malawi REC and South African RECs
 
 
5.4  How well the ethical issues fit the Emanuel et al. (2004, 2008) framework 
When all the queries of the reviewers were coded and counted in the minutes of the 136 protocols, it was 
found that 88.8% of 1,274 queries raised could be accommodated or coded by using the eight Emanuel et al. 
(2008) principles. Queries that could not fit in the framework were coded as language errors (10%) and 
inappropriate referencing and plagiarism (2%) (see Table 3 below). In Table 3, details of the queries have 
been disaggregated by principles and benchmarks. 
 
In terms of ranking the issues by principle, scientific validity was the most frequent principle. This covered 
issues dealing with appropriate study design and methods, with issues raised mostly because of unsound 
statistical methods (64.3%), feasibility of study design (25.2%), and applicability of study findings (9.8%). 
 
Informed consent was ranked as the second most frequently raised concern. Major issues emerging were 
dealing with inadequate information: presentation of accurate information (41%), recruitment and incentives 
not applicable to local context (27%), gatekeeper permission missing (21%), and inadequate disclosure in the 
study documents and processes (21%). 
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The third most frequent queries were issues concerning language errors (10%). These are incomplete 
sentences, grammar, and typographic errors. The Emanuel et al. (2004, 2008) framework does not have a 
principle relating to language issues as these are administrative rather than ethical concerns.  
 
Principle of independent review ranked fourth in the present study. There were concerns regarding lack of 
compliance with REC regulations; 93% issues dealing with regulations of the REC and efforts to minimize 
multiple review (7%). 
 
Collaborative partnerships ranked fifth in the study findings; the concerns were about the sharing of 
responsibilities among research partners and ensuring fair research benefits the host community. The 
principle  of collaborative partnership were about sharing of responsibilities (66.1%), respect for local context 
(13.6%), fair research benefits for communities (10.2%), and community representation (10.2%). 
 
Of the total queries (N =1,274), 4% were about the principle of respect for participants, 4% were on social 
value of the study, 4% were about favourable risk-benefit ratio, 3% were on fair selection of participants, and 
2% were issues to do with inappropriate references and plagiarism. 
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 Table 3: Using the Emanuel et al. (2008) framework to rank queries raised (Ranked descending) 
Principle and benchmarks No. of queries Percent 
 Scientific validity 488 38% 
 3a Appropriate design and methods 314 64.3% 
 3d Study design feasibility 123 25.2% 
 3b Applicability of results 48 9.8% 
 3c Impact on provision of health care 3 0.6% 
  Informed consent 282 22% 
 7c Presentation and accuracy of information 117 41% 
 7a Recruitment and incentive applicability to local context 77 27% 
 7e Gatekeeper permission 58 21% 
 7b Appropriate disclosure documents and processes 22 8% 
 7f Context of consent process 5 2% 
 7g Respect for autonomy 2 1% 
 7d Legally authorized representative 1 0% 
Other 1 (Language errors) 124 10% 
 
9a Language errors (grammar, typing errors, 
incompleteness) 124 100% 
 Independent review 118 9% 
 6a Regulatory compliance 110 93% 
  6b Minimization and reconciliation of multiple reviews 8 7% 
Collaborative partnership  59 5% 
  1b Sharing responsibilities 39 66.1% 
  1c Respect for local context 8 13.6% 
  1d Fair research benefits for community 6 10.2% 
 1a Community representatives 6 10.2% 
 Respect for recruited participants and study communities 49 4% 
  8b Confidentiality and privacy 26 53% 
  8c Voluntariness 12 24% 
  8d Research results dissemination 9 18% 
 8a Monitoring health and well-being 2 4% 
 Social value 47 4% 
  2c Enhancing research benefits 24 51.1% 
  2d Impact on health system 10 21.3% 
  2b Research benefits 9 19.1% 
 2a Research beneficiaries 4 8.5% 
 Favourable risk-benefit ratio 45 4% 
 5a Risk identification and minimization 42 93.3% 
 5b Type, probability, and magnitude of benefits 3 6.7% 
 Fair selection of study population 37 3% 
 4a Suitable study population 18 48.6% 
  4b Risk minimization 12 32.4% 
  4c Benefits to participants 4 10.8% 
  4d Vulnerability 3 8.1% 
 Other 2 (References and plagiarism) 25 2% 
 10a Inappropriate referencing and plagiarism 25 100% 
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 In summary, the findings can be described as follows; 139 protocols were reviewed as initial submissions, 
out of which 3 protocols (2.2%) were approved, 5 protocols (3.7%) were rejected and 131 protocols (94.2%) 
required modification and resubmission for either expedited review or further full REC review. The REC raised 
1274 concerns, and among these 88.8% were accommodated or coded using the eight principles of the 
Emanuel et al. Framework (2008) as follows; scientific validity (38.3%), informed consent (22.1%), 
independent review (9.3%), collaborative partnership (4.7%), respect for recruited participants (3.8%), Social 
value (3.7%) ,favourable risk benefit ratio (3.5%) and fair selection of study population (2.9%). Other queries 
frequently raised were 9.7% language errors and 2.2% inappropriate referencing and plagiarism. These 
results will be discussed in the next chapter. 
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CHAPTER 6: DISCUSSION 
 
6.1  Identifying and ranking ethical concerns raised during research protocol review meeting 
In the present study, most of the REC’s concerns could be coded using the principles and benchmarks of the 
Emanuel et al. (2004, 2008) framework. In terms of using the eight principles and benchmarks, Emanuel and 
colleagues (2004, 2008) cautioned that differences in health, economic, social, and cultural aspects of a 
research setting will affect its application. It is therefore expected that priorities or weights given to particular 
principles in the ethical framework may differ across research settings. However, this differences does not 
mean that the principles and benchmarks are relativistic; rather, it means that the adaptation and balancing 
of universal principles are relative to risk, resources, social practices, and similar circumstances (Emanuel et 
al., 2004).  
 
The Malawian REC most frequently raised issues about the scientific validity of a research project. Scientific 
merit was important to this REC in this setting. These findings contradict some reports that RECs do not pay 
sufficient attention to scientific rigor (Altman, 1994). If study design is unscientific, it affects interpretation 
and the research participants are exposed to unnecessary risk.  Freedman (1987) highlighted that a study 
cannot become ethical by trading some deficiency in scientific worth, even if the researchers can develop 
good consent procedures. Valid design is a non-negotiable requirement. Humphreys et al. (2014) interviewed 
REC members who described that participant safety and ethics factors could only be deemed appropriately 
addressed if the study methods are scientifically sound. They agreed that sound design was necessary for 
approval of a research protocol. In another study by Silaigwana (2017; Silaigwana & Wassenaar, 2019), it was 
reported that some members of a REC (22.25%) felt that it was not their duty to raise queries related to 
scientific validity.  Nonetheless, scientific validity is an international ethical principle (Emanuel et al., 2004, 
2008) and can best be described by quoting Rutstein (1969). 
”It may be accepted as a maxim that a poorly or improperly designed study involving human subjects 
- one that could not possibly yield scientific facts (that is, reproducible observations) relevant to the 
question under study - is by definition unethical. Moreover, when a study is in itself scientifically 
invalid, all other ethical considerations become irrelevant. There is no point in obtaining ‘informed 
consent’ to perform a useless study. A worthless study cannot possibly benefit anyone, least of all 
the experimental subject himself. Any risk to the patient, however small, cannot be justified. In 
essence, the scientific validity of a study on human beings is in itself an ethical principle.” (Rutstein, 
1969, p. 524), 
As mentioned in an earlier section, scientific validity is duly included as an ethical principle in the framework 
by Emanuel et al. (2004, 2008). The current findings suggest that this Malawian REC saw scientific validity as 
an integral element of ethics review and sought to protect participants from invalid and scientifically flawed 
study designs.  Furthermore, the findings show that a significant number of studies reviewed did not fulfil 
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standard requirements for valid research, suggesting the need to strengthen scientific peer review before 
REC submission.  
 
During the study period, most of the reviewed proposals were not sponsored studies or drug trials. Ordinarily 
sponsors play a major role to ensure high quality studies are implemented. A recent study by Happo, 
Halkocho, Lehto and Keranen (2016) found that most concerns relating to study methods arose from non-
industry sponsored clinical trial. These were research protocols that did not involve physical procedures. 
CIOMS (2016) states that research conducted in low- and middle-income countries must be submitted to and 
approved by RECs in both sponsor and host countries. The lack of sponsorship may have adversely influenced 
the scientific quality of studies submitted to the Malawian REC. Likewise, more than half of studies which 
were reviewed during the study period were cross-sectional studies. Researchers may have had limited 
resources to hire experts to assist with designing their studies. Partnership or collaboration to improve 
scientific research design may be required and encouraged among Malawian researchers.   
 
As indicated earlier the present study is a replication of a study by Tsoka-Gwegweni and Wassenaar, (2014). 
Present findings show that the issues frequently raised are similar, although the order of priority is different. 
In Malawi, Informed consent was the second most frequently raised concern while in South Africa this was 
the most frequently raised issue. Another study done on RECs elsewhere found that informed consent was 
the most queried issue (Dixon-Woods, 2008).  In addition Lidz et al. (2012) also reported that 98% of the 
reviews in their study raised questions about informed consent. The Malawian REC was concerned about 
inaccurate information given to the participants, incentives that were not applicable to local context, and 
lack of gatekeepers’ permission and requests for waiver of consent. The REC was assessing the information 
in the consent forms considering the literacy levels of most study participants. There is a general presumption 
that informed consent must be obtained in research involving humans unless a waiver of consent is approved 
by the REC. The quality of information given to the research participant is crucial. Authors like Beauchamp 
and Childress (2013) have explained that for many years obtaining consent was marked as a primary 
obligation for researchers, but in recent years, the focus has shifted from the researchers’ obligations and 
now it is about disclosing information appropriate to the quality of the subjects’ understanding and ability to 
consent, thus suggesting that quality of informed consent is key. These findings suggest that applicants need 
to apply this shifting dynamic and invest more effort into the development of necessary approaches to ensure 
research participants are receiving accurate and easy-to-understand information in order to facilitate valid 
informed consent. There were cases in which researchers were seeking a waiver of consent. The waiver of 
consent policy in Malawi is very strict but the REC can explore conditions which may allow the consent form 
to be waivered or altered. 
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In Malawi, informed consent is a legislative requirement enshrined in section 19.5 of the Constitution of 
Malawi which states: “No person shall be subjected to medical or scientific experiment without his or her 
consent” (Constitution of the Republic of Malawi, 1996).  Ordinarily, Malawian RECs do not allow a waiver of 
consent for studies involving identifiable research participants.  
 
Most of the issues raised within the third-ranked principle of independent review were related to compliance 
with REC regulations such as payment of review fees and not including the ten percent research budget. Most 
often, applicants were requesting a waiver despite their eligibility to pay the required fees. It must be noted 
that an ideal REC must be well-financed and, considering the Malawian setting, the most practical way to 
finance the REC is through collecting such revenue. However, it is also a burden on researchers who are not 
sponsored. The regulations may also influence some researchers who are sponsored to submit false budgets 
for review. In addition, there were issues dealing with improper documentation of material transfer 
agreements. Malawian RECs do not approve sample collection and storage for unspecified study, hence 
material agreement forms were receiving much scrutiny. In some cases, investigators were requested to 
provide REC approval if the researcher stated there was more than one REC reviewing the protocol.  
 
In the present study, almost five percent of all queries focused on the fourth-ranked principle of collaborative 
partnership. In the South African study (Tsoka-Gwegweni & Wassenaar, 2014), it was only three percent of 
queries. A majority of the concerns focused on asking for collaborating investigators to clearly document 
their roles in the protocol and the need to consider or respect cultural values in the selected study area. 
These results suggest that the REC is working to ensure fairness in the distribution of burden to conduct 
research and benefits among collaborators. Anecdotal evidence suggests that some investigators are 
included in the protocol for the sake of honour and sometimes even included during publication as gift 
authors. Asking the applicants to clearly indicate their roles and responsibilities may be a deliberate effort to 
bring about fairness among local and international investigators. Furthermore, an issue worth noting is the 
history of this particular principle in the Malawian setting. Initially the Emanuel et al. framework had seven 
principles (Emanuel et al., 2004). Later, the eighth principle of collaborative partnership was added (Emanuel 
et al., 2008). In his book Mfutso-Bengo (2016) reports that, in 2001, Malawi hosted a National Institutes of 
Health (NIH)-funded international conference, which was attended by over 200 African and international 
delegates to discuss emerging bioethical issues in Africa. Out of this bioethics conference, one additional 
concept that emerged was the concept of collaborative partnership and was added to the seven previous 
research ethics principles listed by Emanuel and colleagues (Emanuel et al, 2000). The present study found 
that queries relating to the collaborative partnership principle were considerably higher compared to South 
African findings. We can speculate that the 2001 conference may have had a lasting impact on Malawian 
RECs to put substantial value on this principle, unless the variance is due to coding differences. 
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The principles of respect for recruited participants, favourable risk-benefit ratio, and fair selection of study 
population directly relate to participants’ well-being. The data from the study show there were very few 
clinical trials but more cross-sectional studies. Furthermore, a number of protocols had non-physical 
procedures hence considered lower risk studies. It is therefore not surprising that very few concerns were 
raised that are directly affecting a study participant’s well-being compared to the SA study which had at least 
31 clinical trials.  In some protocols, the principle of social value was raised where it was deemed that the 
research activity was likely to compromise health service delivery at a health facility.  
 
6.2  Issues commonly raised during review meeting that were not accommodated by the Emanuel et 
al (2008) Framework 
Some other concerns frequently raised could not be accommodated in the framework such as grammar, 
typographic errors, inappropriate referencing, and plagiarism. These were coded as ‘other’ additional 
concerns. According to the recorded minutes, ten percent of all queries exhibited typographic errors. These 
are not ethical issues but were identified and considered unacceptable by the REC. We can only speculate 
that the applicants rush through their work in order to submit within REC deadlines and that might prevent 
them from having their work edited for language and grammar. Cleaton-Jones (2010) reported that 15 
percent of applications to the University of Witwatersrand REC received queries related to typing errors and 
incomplete applications. On the other hand, Amdur and Bankert (2011) suggested that typos should not be 
raised in REC’s review unless meaning is obscured.  In most of the concerns raised in the present study, the 
REC was requesting the applicant to proof-read the entire protocol due to numerous typing errors that made 
the meaning unclear. The secretariat of the REC must ensure completeness of the submissions and should 
not accept incomplete applications; only completed applications should be sent for review by the committee. 
Considering that most Malawian REC members are academics, applicants need to put in more effort and 
proof-read the entire protocol before submission.  
 
Similarly, issues of inappropriate referencing and plagiarism were raised frequently. Among the highlighted 
issues were cases where the applicants were informed that the references provided did not contain the 
concepts or the data cited in the section or paragraph. Wassenaar (2006) highlights that the original purpose 
of research ethics is to protect the welfare of research participants but its concerns are now extending into 
areas such as scientific misconduct and plagiarism. It is commendable if RECs are able to identify and raise 
plagiarism concerns although it is difficult to identify plagiarism manually unless technology tools such as 
Turnitin are in used as part of the pre-review analysis, possibly by the REC secretariat.   
 
6.3  Limitations of this study  
Despite involving two trained coders for the content analysis, it is possible that some concerns raised in the 
minutes were not coded correctly, as such it has a bearing on the frequencies of principles used. In 
addition, the years sampled my not adequately represent the work of the REC over many years.  
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6.4  Conclusion 
This content analysis of a Malawian REC minutes has identified the most frequently raised ethical issues 
during protocol review meetings and the pattern of issues raised. Most of the issues frequently raised could 
be accommodated by the Emanuel et al. (2004, 2008) framework. Scientific validity and informed consent 
issues were frequently raised. The top ranked concerns were directed at the investigators to ensure 
appropriate study design, followed by consent-related issues.  The quality of science in the protocols and the 
quality of information given to participants were prioritised. The Malawian and South African RECs studied 
so far have therefore put much weight onto these two principles of the Emanuel et al framework (2008), 
suggesting that these issues may warrant further careful attention by future research ethics applicants, and 
should be a focus of research and research ethics training. 
 
6.5   Recommendations 
1. Scientific peer review within research institutions should be promoted and encouraged before 
Protocol submission for REC approval. This may reduce the relatively high number of scientific validity 
queries raised by the REC. 
2. Malawian Researchers who are self-funded should consider collaborating with experts in study 
design and analysis because employing an Epidemiologist or statistician may be expensive.  If 
collaboration is challenging, the researchers must consider involving the services of the Research 
Support Centre at College of Medicine to strengthen the quality of science in the research protocol. 
This may also reduce the relatively high number of scientific validity queries raised by the REC. 
3. Researchers should consider involving language editors to proof read their protocols before REC 
submission. This may reduce the relatively high number of typos and grammatical queries raised by 
the REC. In turn, REC members should be trained not to raise grammatical queries unless they 
obscure the meaning of the protocol. 
4. The Malawian REC should consider developing a standard informed consent guidance template to 
ensure that researchers addressing all the legally and ethically required issues in the Malawian 
context. This may reduce the relatively high number of informed consent related queries raised by 
the REC 
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Appendix I: Request for permission to access protocol review minutes from UKZN thesis Supervisor 
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Appendix II:  Support letter requesting for permission to access protocol review minutes  
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Appendix III: Certificate of Ethics Approval from COMREC 
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Appendix IV: Protocol Amendment Approval from COMREC 
 
  
COLLEGE OF MEDICINE  
Principal                         College of Medicine  
M. H. C. Mipando MSc PhD                            Private Bag 360  
                          Chichiri  
                          Blanytre 3  
Our Ref:                              Malawi  
                          Telephone:  01 871911 Your Ref: P.10/16/2051           01 874107  
                                 Fax: 01 874 700  
1st February 2017  
 
Ms. Tiwonge Mtande  
C/O Mr. Sunganani Mtande  
Times Group  
P/Bag 39  
BLANTYRE  
 
 
Dear Ms. Mtande,  
 
RE:  P.10/16/2051 – Ethical issues raised by a Malawian research ethics committee version 1.2 
dated 05/09/2016  
 
 
I write to inform you that COMREC reviewed the amendment to the above captioned proposal 
which you submitted for review. I am pleased to inform you that COMREC approved the 
following amendment:  
 
1. To change duration of minutes to be studied from (2012-2013) to (2013-2014)   
 
As you proceed with implementation, please adhere to the college requirements per attached 
page.  
 
Yours Sincerely,  
 
  
Dr. YB  Mlombe  
COMREC CHAIRMAN  
 
YM/ck  
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REQUIREMENTS FOR ALL COMREC APPROVED RESEARCH PROTOCOLS  
 
 
1. Pay the research fees as required by College of Medicine for all approved studies.  
  
2. You should note that the follow-up committee will monitor the conduct of the approved 
protocol and any deviation from the approved protocol may result in your study being 
withdrawn.  
  
3. You will provide an interim report in the course of the study and an end of study report.  
  
4. You are required to obtain a continuation approval after 12 months from the date of 
approval.   
  
5. All investigators must be fully registered with the Medical Council of Malawi.  
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Appendix V: UKZN BREC Approval 
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Appendix VI: Data collection sheet 
 
REC Codename: __________ 
Protocol no: _________ 
Instruction: Review recorded minutes of each protocol reviewed, code the frequency with which the 
following issues were raised. Some issues can occur several times in the review of a single protocol, these 
must be included. 
1. Collaborative Partnership 
a. Community representatives 
b. Responsibility sharing  
c. Respect for local context 
d. Fair research benefits for community 
e. Sharing research products 
2. Social Value 
a. Research beneficiaries 
b. Research benefits 
c. Enhancing research benefits 
d. Impact on health systems  
3. Scientific Validity 
a. Appropriate design and methods 
b. Applicability of results 
c. Impact on provision of health care services 
d. Study design feasibility  
4. Fair Participant Selection  
a. Suitable study population 
b. Risk minimization 
c. Benefits to participants 
d. Vulnerability 
5. Favourable risk–benefit ratio 
a. Risks identification and minimization 
b. Type, probability and magnitude of benefits 
c. Comparison of risks and benefits  
6. Independent Ethics Review 
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a. Regulatory compliance 
b. REC members conflict of interest  
c. Transparent review 
d. Minimization and reconciliation of multiple reviews 
7. Informed Consent  
a. Recruitment & incentives applicability to local context 
b. Appropriate disclosure documents and processes 
c. Presentation and accuracy of information 
d. Legally authorized representatives 
e. Gatekeeper’s permission 
f. Context of consent process 
g. Respect for autonomy 
8. Ongoing respect for participants 
a. Monitoring health and well-being 
b. Confidentially and privacy 
c. Voluntariness 
d. Research results dissemination 
e. Post-research obligations  
9. Other 1  
10. Other 2  
11. Other 3 
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Appendix VII: REC A Review Of Research Protocols 
 
TITLE OF STUDY:_____________________________________________________________ 
 
PRINCIPAL INVESTIGATOR:  _________________________________________________ 
REVIEWER:  _________________________________________________________________ 
DATE OF REVIEW: ___________________________________________________________ 
OVERALL  RECOMMENDATION:  _____________________________________________ 
 
1.  Briefly summarize proposed research.  What is the research about, how will it be done  
     and why is it important to do the study.  Comment on its strength and/or weakness 
 
 
 
 
 
 
 
 
 
 
SCIENTIFIC SECTION: 
1.  Comment on the objective (s) and design of study 
 
 
 
 
 
 
 
  
66 
 
 
2.  Comment on the proposed methods to address the objectives 
 
 
 
 
 
 
 
3.  Comment on the setting, study population, recruitment process 
 
 
 
 
 
4.  Comment on sample size calculation and selection of sample 
 
 
 
 
 
 
 
 
5.  Comment on data collection method and statistical analysis 
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6.  Comment on factual accuracy or error in the protocol 
 
 
 
 
 
 
 
 
ETHICAL SECTION  
 
1.  Comment on the risks involved, have they been all identified? 
 
 
 
 
 
 
 
 
 
2.  Comment on the informed consent, have all the risks been explained in the consent form.   
     Have they been adequately addressed? 
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3.  Comment on any other risk that may occur as a result of participation in the  
      study/standard of care issue 
 
 
 
 
 
 
4.  Comment on whether the confidentiality, direct benefits, indirect benefits 
 
 
 
 
 
 
 
 
5.  Comment on possible Adverse Events and how they will be addressed 
 
 
 
 
 
6.  Comment on sample collection, storage and testing/shipping samples outside the  
     country.  Justification of, or shipment of sample 
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7.  Comment on randomization/use of placebo if applicable 
 
 
 
 
 
 
 
 
 
 
ADMINISTRATIVE SECTION 
 
1.  Comment on the adequacy of budget to conduct study 
 
 
 
 
 
 
 
 
 
2.  Comment on the personnel including the qualifications of the investigation team 
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3.  Comment on presentation format errors: indicate page, paragraph and error 
 
 
 
 
 
 
 
 
 
4.  Comment on any direct benefit to College, Department, etc 
 
 
 
 
 
 
 
 
 
 
DECISION – Give reasons for approval/not approved or any other recommendations 
 
 
 
 
 
 
 
 
